Central Bank & Trust CO Edwards Lifesciences Corp Transaction History

Central Bank & Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	BUY	$61.71 - $77.76 $186,549 - $235,068	3,023 New	3,023 $230,000
Q1 2023 Apr 13, 2023	BUY	$74.26 - $84.51 $2,450 - $2,788	33 New	33 $2,000
Q2 2022 Jul 22, 2022	BUY	$86.5 - $128.27 $3,373 - $5,002	39 New	39 $4,000
Q1 2022 Apr 18, 2022	SELL	$101.96 - $128.34 $39,968 - $50,309	-392 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$78.68 - $90.67 $30,842 - $35,542	392 New	392 $33,000
Q2 2019 Jul 16, 2019	SELL	$55.74 - $64.41 $3,455 - $3,993	-62 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$46.41 - $56.94 $1,531 - $1,879	-33 Reduced 34.74%	62 $9,000
Q3 2018 Nov 23, 2018	BUY	$45.7 - $58.03 $4,341 - $5,512	95 New	95 $17,000

1,362

467M

9.76M

3.89M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.